Delivery Order SPE2DB20D3103-SPE2DB22FP2N3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,453.50 firm fixed-price delivery order is for Timolol Maleate 0.5% eye drops in 60-count units. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,393.48, is for the delivery of Timolol Maleate 0.5% eye drops in 60-count units. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of November 15, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $7,332.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FCVYE) for the supply of Timolol Maleate 0.5% eye drops in unit-dose packaging. The contract has a firm fixed price and an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Timolol Maleate 0.5% eye drops in unit dose 60s packaging. The firm-fixed-price delivery order, valued at $1,173.52, has an ultimate completion date of January 25, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,644.05 firm fixed-price contract is for the supply of Timolol Maleate 0.5% eye drops in a 60-count unit dose format. The contract has an ultimate completion date of July 12, 2024. AmerisourceBergen is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger...
- This federal contract award is a delivery order with a firm fixed price of $1,387.04 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565440519 - Timolol Maleate 0.5% Eye Drops, 15ml, with a completion date of August 14, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp maintains a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Timolol Maleate 0.5% eye drops, with a total ceiling value of $1,048.32 and a completion date of September 21, 2022. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award, SPE2DX15D1022|SPE2DX24FVDNN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,421.94 firm fixed-price delivery order is for Timolol Maleate 0.5% eye drops in 60-unit doses. The contract has an ultimate completion date of February 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,159.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Timolol Maleate 0.5% eye drops, with a completion date of May 8, 2023. No set-aside designation was used for this award. Amerisourcebergen holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Timolol Maleate 0.5% eye drops. The contract is a Delivery Order with a Firm Fixed Price of $2,821.96 and an Ultimate Completion Date of April 18, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award. The company holds a larger...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP2N3Delivery Order
This federal contract award, with a total ceiling value of $1,048.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Timolol Maleate 0.5% eye drops in unit doses of 60 units. This is a firm-fixed-price delivery order contract with a completion date of July 21, 2022. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/20/22 |